Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yong-Song Guan, Qing He & Mei Li. (2014)
Icotinib: activity and clinical application in Chinese patients with lung cancer. Expert Opinion on Pharmacotherapy 15:5, pages 717-728.
Read now
Read now
Klaus Koefoed, Lucilla Steinaa, Josefine Nielsen Søderberg, Ida Kjær, Helle Jane Jacobsen, Per-Johan Meijer, John Sørensen Haurum, Allan Jensen, Michael Kragh, Peter Sejer Andersen & Mikkel Wandahl Pedersen. (2011) Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor. mAbs 3:6, pages 584-595.
Read now
Read now
Articles from other publishers (35)
Jing Yang, Yanfei Yang, Yuquan Wei & Xiawei Wei. (2023) A small-molecule pan-HER inhibitor alone or in combination with cisplatin exerts efficacy against nasopharyngeal carcinoma. Frontiers of Medicine 17:2, pages 275-289.
Crossref
Crossref
Guangyao Li, Tian Li, Wenyan Fu, Changhai Lei & Shi Hu. 2023. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies
35
40
.
Guangyao Li & Shi Hu. 2023. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies
69
74
.
Yimin Yao, Ziwei Qi, Qingqing Zhu, Qi Zhao, Zheng Zhang, Shilong Fu, Liyao Zhou, Jiaxing Zhu, Zhenhua Liu, Haiyan Xu, Yuhui Huang, Jiao Xue & Songbing Qin. (2021)
Erb‐(IL10)
2
induces abscopal antitumor effects of radiotherapy through the activation and recruitment of lymph node CD8
+
T cells
. Precision Radiation Oncology 5:4, pages 226-236.
Crossref
Crossref
Amina Majeed Hassan, Adil Muala Dhumad, Rafid Al-Asadi & Ahmed Majeed Jassem. (2020) Synthesis And Molecular Docking Of Some Amic Acid Targeting Breast Cancer. IOP Conference Series: Materials Science and Engineering 928:5, pages 052022.
Crossref
Crossref
Md. Lutful Kabir, Frederick Backler, Andrew H. A. Clayton & Feng Wang. (2020) Deducing the Conformational Properties of a Tyrosine Kinase Inhibitor in Solution by Optical Spectroscopy and Computational Chemistry. Frontiers in Chemistry 8.
Crossref
Crossref
Majid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, Hassan Yousefi, Sepehr Javadikooshesh, Vasimeh Vahdatirad, Zivar Alishahi, Seyedeh H. Mousavipak, Davood Bashash, Ahmad R. Dehpour, Seyyed M. Tavangar, Javad Tavakkoly-Bazzaz, Peiman Haddad, Farzaneh Kordbacheh, Kamran Alimoghaddam, Ardeshir Ghavamzadeh & Seyed H. Ghaffari. (2019) The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. Cellular Oncology 42:4, pages 491-504.
Crossref
Crossref
Ye Won Chung, Seongmin Kim, Jin Hwa Hong, Jae Kwan Lee, Nak Woo Lee, Young Seok Lee & Jae Yun Song. (2019) Overexpression of HER2/HER3 and clinical feature of ovarian cancer. Journal of Gynecologic Oncology 30:5.
Crossref
Crossref
Manni Wang, Yuzhu Hu, Ting Yu, Xuelei Ma, Xiawei Wei & Yuquan Wei. (2018) Pan-HER-targeted approach for cancer therapy: Mechanisms, recent advances and clinical prospect. Cancer Letters 439, pages 113-130.
Crossref
Crossref
Shima Moradi-Kalbolandi, Aysooda Hosseinzade, Malihe Salehi, Parnaz Merikhian & Leila Farahmand. (2018) Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER. Journal of Pharmacy and Pharmacology 70:7, pages 841-854.
Crossref
Crossref
Rosalin Mishra, Hima Patel, Samar Alanazi, Long Yuan & Joan T. Garrett. (2018) HER3 signaling and targeted therapy in cancer. Oncology Reviews.
Crossref
Crossref
Maria Rosestedt, Ken G. Andersson, Bogdan Mitran, Sara S. Rinne, Vladimir Tolmachev, John Löfblom, Anna Orlova & Stefan Ståhl. (2017) Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression. International Journal of Oncology 51:6, pages 1765-1774.
Crossref
Crossref
Stefania Napolitano, Giulia Martini, Erika Martinelli, Valentina Belli, Alessia Parascandolo, Mikko O. Laukkanen, Vincenzo Sforza, Floriana Morgillo, Davide Ciardiello, Fortunato Ciardiello & Teresa Troiani. (2017) Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation. Oncotarget 8:40, pages 67592-67604.
Crossref
Crossref
Brigitte Rack, Ewa Zombirt, Elisabeth Trapp, Julia Jückstock, Ulrich Andergassen, Julia Neugebauer, Bernd Kost, Tobias Weissenbacher, Udo Jeschke, Christian Schindlbeck, Wolfgang Janni & Marianna Alunni-Fabbroni. (2016) Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients. Oncology 90:4, pages 232-238.
Crossref
Crossref
Ningyan Zhang, Yujun Chang, Adan Rios & Zhiqiang An. (2016) HER3/ErbB3, an emerging cancer therapeutic target. Acta Biochimica et Biophysica Sinica 48:1, pages 39-48.
Crossref
Crossref
Xiaochun Wang, Kathleen M. Batty, Philip J. Crowe, David Goldstein & Jia-Lin Yang. (2015) The Potential of panHER Inhibition in Cancer. Frontiers in Oncology 5.
Crossref
Crossref
Jeong A. Bae, Somy Yoon, So-Yeon Park, Jae Hyuk Lee, Jun-Eul Hwang, Hangun Kim, Young-Woo Seo, Yoon Jin Cha, Sung Pil Hong, Hoguen Kim, Ik Joo Chung & Kyung Keun Kim. (2014) An Unconventional KITENIN/ErbB4-Mediated Downstream Signal of EGF Upregulates c-Jun and the Invasiveness of Colorectal Cancer Cells. Clinical Cancer Research 20:15, pages 4115-4128.
Crossref
Crossref
Mariaelena Pierobon, Julie Wulfkuhle, Lance A. Liotta & Emanuel F. PetricoinIII.III.. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer
367
383
.
A. D. Hartkopf, M. Banys, F. Meier-Stiegen, M. Hahn, C. Röhm, J. Hoffmann, G. Helms, F. A. Taran, M. Wallwiener, C. Walter, H. Neubauer, D. Wallwiener & T. Fehm. (2013) The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse. Breast Cancer Research and Treatment 138:2, pages 509-517.
Crossref
Crossref
Shyhmin Huang, Chunrong Li, Eric A. Armstrong, Chimera R. Peet, Jarob Saker, Lukas C. Amler, Mark X. Sliwkowski & Paul M. Harari. (2013) Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation. Cancer Research 73:2, pages 824-833.
Crossref
Crossref
Michael Boyer, Pasi Antero Jänne, Tony Mok, Kenneth O’Byrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph O’Connell, Stephen Letrent & Vladan Antic. (2013) Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer. Clinical Investigation 3:1, pages 29-35.
Crossref
Crossref
Byung-Kwon Choi, Xiumei Cai, Bin Yuan, Zhao Huang, Xuejun Fan, Hui Deng, Ningyan Zhang & Zhiqiang An. (2012) HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways. Protein & Cell 3:10, pages 781-789.
Crossref
Crossref
Van A. Trinh & Wen-Jen Hwu. (2011) Chemoprevention for Brain Metastases. Current Oncology Reports 14:1, pages 63-69.
Crossref
Crossref
Diana CrivellariSimon SpazzapanDavide LombardiLoredana Militello, Elena Torrisi, Alessia E Russo, Roberto SorioRenato Talamini, Gianmaria MioloPaolo CarliAndrea Veronesi. (2018) Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single Institution Experience. Tumori Journal 98:1, pages 33-38.
Crossref
Crossref
Mariaelena Pierobon, Julie Wulfkuhle, Lance A. Liotta & Emanuel F. PetricoinIIIIII. 2012. Systems Biology in Cancer Research and Drug Discovery. Systems Biology in Cancer Research and Drug Discovery
309
323
.
Andreas D. Hartkopf, Malgorzata Banys & Tanja Fehm. 2012. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
203
215
.
David M. Goldenberg & Robert M. Sharkey. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
125
138
.
Ngayu Thairu, Serafim Kiriakidis, Peter Dawson & Ewa Paleolog. (2011) Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14:3, pages 223-234.
Crossref
Crossref
Karin Haim, Polina Weitzenfeld, Tsipi Meshel & Adit Ben-Baruch. (2011) Epidermal Growth Factor and Estrogen Act by Independent Pathways to Additively Promote the Release of the Angiogenic Chemokine CXCL8 by Breast Tumor Cells. Neoplasia 13:3, pages 230-243.
Crossref
Crossref
Luke L Gompels, Nasser M Malik, Leigh Madden, Pei Jin, Marc Feldmann, H Michael Shepard & Ewa M Paleolog. (2011) Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade. Arthritis Research & Therapy 13:5, pages R161.
Crossref
Crossref
Richard Greil, Simona Borštnar, Katarína Petráková, Yiola Marcou, Joanna Pikiel, Marek Z. Wojtukiewicz, Ivan Koza, Günther G. Steger, Meinolf Linn, Ash Das Gupta & Karel Cwiertka. (2011) Combination Therapy of Lapatinib and Capecitabine forErbB2-Positive Metastatic or Locally Advanced BreastCancer: Results from the Lapatinib Expanded AccessProgram (LEAP) in Central and Eastern Europe. Onkologie 34:5, pages 233-238.
Crossref
Crossref
Mariaelena Pierobon, Claudio Belluco, Lance A. Liotta & Emanuel F. PetricoinIIIIII. 2011. Protein Microarrays. Protein Microarrays
3
12
.
Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni & Franca Podo. (2010) Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells. Breast Cancer Research 12:3.
Crossref
Crossref
David Lesniak, Yaoxian Xu, Jean Deschenes, Raymond Lai, John Thoms, David Murray, Sunita Gosh, John R. Mackey, Siham Sabri & Bassam Abdulkarim. (2009) β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer. Cancer Research 69:22, pages 8620-8628.
Crossref
Crossref
Menghong Sun, Carmen Behrens, Lei Feng, Natalie Ozburn, Ximing Tang, Guosheng Yin, Ritsuko Komaki, Marileila Varella-Garcia, Waun Ki Hong, Kenneth D. Aldape & Ignacio I. Wistuba. (2009) HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors. Clinical Cancer Research 15:15, pages 4829-4837.
Crossref
Crossref